Previously, CD14+ monocytes from a different dataset (BLUEPRINT)41 have been used in a multi-tissue TWAS study of Alzheimer’s disease,42 alongside expression data from GTEx, using a smaller GWAS43 than that used here. This evidence concerns the gene CD14 and early-onset autosomal dominant Alzheimer disease.